Sale!

Liquid Biopsy Lung Cancer Test

Original price was: $1,000.Current price is: $826.

-17%

The Liquid Biopsy Lung Cancer Test is a revolutionary non-invasive diagnostic tool that detects cancer-related genetic mutations through a simple blood draw. Using Next-Generation Sequencing (NGS) technology, this test analyzes circulating tumor DNA (ctDNA) to identify specific genetic alterations associated with lung cancer. Priced at $826 USD, this advanced screening method provides crucial information for early detection, treatment monitoring, and personalized therapy selection. The test requires a blood sample collected in a Streck tube and delivers results within 21 working days. Ideal for individuals with lung cancer symptoms, family history, or those undergoing cancer treatment monitoring.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Liquid Biopsy Lung Cancer Test

Revolutionary Non-Invasive Cancer Detection

The Liquid Biopsy Lung Cancer Test represents a groundbreaking advancement in cancer diagnostics, offering a minimally invasive alternative to traditional tissue biopsies. This innovative test analyzes circulating tumor DNA (ctDNA) present in the bloodstream, providing comprehensive genetic information about lung cancer without the need for invasive surgical procedures. Using state-of-the-art Next-Generation Sequencing (NGS) technology, our test delivers precise molecular profiling that guides personalized treatment decisions and monitors treatment response.

What This Test Measures and Detects

Our Liquid Biopsy Lung Cancer Test employs sophisticated NGS methodology to identify specific genetic mutations and alterations associated with lung cancer development and progression. The test comprehensively analyzes:

  • EGFR mutations for targeted therapy eligibility
  • ALK rearrangements and fusion genes
  • KRAS mutations affecting treatment response
  • BRAF alterations for precision medicine approaches
  • MET amplifications and exon 14 skipping mutations
  • ROS1 rearrangements and other driver mutations
  • Tumor mutation burden (TMB) for immunotherapy assessment
  • Microsatellite instability (MSI) status

Who Should Consider This Test

This advanced diagnostic test is particularly beneficial for individuals experiencing:

  • Persistent cough lasting more than 3 weeks
  • Unexplained chest pain or discomfort
  • Shortness of breath or wheezing
  • Coughing up blood or rust-colored phlegm
  • Unexplained weight loss and fatigue
  • Hoarseness or voice changes
  • Recurrent respiratory infections
  • Family history of lung cancer
  • Current or former smokers with risk factors
  • Patients undergoing lung cancer treatment monitoring

Key Benefits of Liquid Biopsy Testing

Early Detection and Intervention

Liquid biopsy enables early detection of lung cancer at molecular levels, allowing for timely intervention before symptoms become severe. This non-invasive approach provides crucial genetic information that can guide preventive measures and early treatment strategies.

Personalized Treatment Planning

By identifying specific genetic mutations, our test helps oncologists develop targeted treatment plans tailored to your unique cancer profile. This precision medicine approach increases treatment effectiveness while minimizing unnecessary side effects.

Real-Time Treatment Monitoring

Unlike traditional biopsies that provide a single snapshot, liquid biopsy allows for continuous monitoring of treatment response and cancer progression. This dynamic assessment helps physicians adjust therapies as needed for optimal outcomes.

Minimal Discomfort and Risk

The test requires only a simple blood draw, eliminating the risks associated with invasive tissue biopsies. Patients experience minimal discomfort and can resume normal activities immediately after sample collection.

Understanding Your Test Results

Your Liquid Biopsy Lung Cancer Test results will provide comprehensive information about detected genetic mutations and their clinical significance. Our detailed report includes:

  • Specific mutation profiles identified
  • Clinical implications of each finding
  • Recommended targeted therapies
  • Interpretation guidelines for healthcare providers
  • Follow-up testing recommendations if needed

Positive results indicate the presence of cancer-associated genetic mutations, while negative results suggest no detectable mutations at the time of testing. It’s important to discuss your results with your healthcare provider for proper interpretation and next steps.

Test Pricing and Details

Test Feature Details
Test Name Liquid Biopsy Lung Cancer Test
Regular Price $1000 USD
Discount Price $826 USD
Turnaround Time 21 Working Days
Sample Type Blood
Test Components Streck Tube
Methodology Next-Generation Sequencing (NGS)

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving patients in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified facilities ensures that advanced genetic testing is accessible to patients nationwide.

Take Action for Your Health Today

Don’t wait to get the answers you need for your lung health. Our Liquid Biopsy Lung Cancer Test provides critical information that can guide your healthcare journey and potentially save lives through early detection. Contact us today to schedule your test and take control of your health.

Call or WhatsApp us at +1(267) 388-9828 to book your Liquid Biopsy Lung Cancer Test today!

Our experienced healthcare professionals are ready to answer your questions, explain the testing process, and help you take the next step toward comprehensive lung cancer screening and monitoring.